These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17487372)

  • 1. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
    Ray A; Nkhata KJ; Cleary MP
    Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
    Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
    Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adiponectin and leptin co-treatment on human breast cancer cell growth.
    Nkhata KJ; Ray A; Schuster TF; Grossmann ME; Cleary MP
    Oncol Rep; 2009 Jun; 21(6):1611-9. PubMed ID: 19424644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-induced obesity and mammary tumor development in relation to estrogen receptor status.
    Ray A; Nkhata KJ; Grande JP; Cleary MP
    Cancer Lett; 2007 Aug; 253(2):291-300. PubMed ID: 17399892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
    Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
    Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.
    Bowers LW; Wiese M; Brenner AJ; Rossi EL; Tekmal RR; Hursting SD; deGraffenried LA
    PLoS One; 2015; 10(12):e0145452. PubMed ID: 26709918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.
    Hu X; Juneja SC; Maihle NJ; Cleary MP
    J Natl Cancer Inst; 2002 Nov; 94(22):1704-11. PubMed ID: 12441326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
    Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
    Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin induces a proliferative response in breast cancer cells but not in normal breast cells.
    Dubois V; Jardé T; Delort L; Billard H; Bernard-Gallon D; Berger E; Geloen A; Vasson MP; Caldefie-Chezet F
    Nutr Cancer; 2014; 66(4):645-55. PubMed ID: 24738610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli.
    Garofalo C; Koda M; Cascio S; Sulkowska M; Kanczuga-Koda L; Golaszewska J; Russo A; Sulkowski S; Surmacz E
    Clin Cancer Res; 2006 Mar; 12(5):1447-53. PubMed ID: 16533767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
    Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
    Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models.
    Go RE; Kim CW; Lee SM; Lee HK; Choi KC
    Food Chem Toxicol; 2021 Mar; 149():112000. PubMed ID: 33484789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
    Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
    Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.
    Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML
    Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.
    Saxena NK; Vertino PM; Anania FA; Sharma D
    J Biol Chem; 2007 May; 282(18):13316-25. PubMed ID: 17344214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.